HomeMRKR • NASDAQ
add
Marker Therapeutics Inc
Previous close
$1.34
Day range
$1.27 - $1.38
Year range
$0.81 - $4.07
Market cap
22.34M USD
Avg Volume
148.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.10M | -51.00% |
Operating expense | 3.29M | 220.78% |
Net income | -1.70M | 55.62% |
Net profit margin | -154.35 | 9.43% |
Earnings per share | -0.04 | 90.48% |
EBITDA | — | — |
Effective tax rate | 0.88% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.07M | -16.28% |
Total assets | 19.07M | -13.40% |
Total liabilities | 2.27M | -34.36% |
Total equity | 16.80M | — |
Shares outstanding | 16.67M | — |
Price to book | 1.33 | — |
Return on assets | -23.08% | — |
Return on capital | -26.77% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.70M | 55.62% |
Cash from operations | -1.90M | 59.60% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -1.90M | -118.64% |
Free cash flow | -1.53M | 53.22% |
About
Founded
1992
Headquarters
Website
Employees
5
